Vector Blog

Two resilient dogs point to new targets for Duchenne muscular dystrophy

Two golden retrievers that had the genetic mutation for Duchenne muscular dystrophy (DMD), yet remained healthy, have offered up yet another lead for treating this muscle-wasting disorder. For several years, Natássia Vieira, PhD, of the University of São Paolo, also a fellow in the Boston Children’s Hospital lab of Louis Kunkel, PhD, has been studying a Brazilian...

The post Two resilient dogs point to new targets for Duchenne muscular dystrophy appeared first on Vector.

Predicting influenza outbreaks faster with a digitally-empowered wearable device

The Thermia online health educational tool, developed at Boston Children’s Hospital, has enabled one-month-faster prediction of seasonal influenza outbreaks in China, via its digital integration with a commercially-available wearable thermometer. The findings appear in a new study published in the American Journal of Public Health.  “The fact that we were able to predict influenza outbreaks faster than China’s...

The post Predicting influenza outbreaks faster with a digitally-empowered wearable device appeared first on Vector.

Who We are

The mission of the Technology and Innovation Development Office (TIDO) to maximize the impact of Boston Children’s innovations on patient health while enhancing the research endeavor.

News and Events

TIDO, the Manton Center, and MassBio will co-host a Boston Children’s Rare Disease Networking Event on May 25th from 4:30 – 7:00 pm at MassBio Headquarters in Cambridge. This event will showcase Children’s research in rare diseases and discuss advancing new therapy development through industry-academic collaborations. The program will include an academic-industry panel featuring our CSO David Williams, MD, Manton Center Director Alan Beggs, PhD, Philip Reilly, MD, JD, of Third Rock Ventures, and Alvin Shih, MD, of Enzyvant. In addition, there will be short research talks by Boston Children’s researchers and networking sessions with posters. Register to attend by clicking the above title.

TIDO is proud to announce the release of our new Inventor’s Guide. The booklet details the commercialization process at Boston Children’s, how to work with TIDO to give your invention the best possibility for success, and answers to frequently asked questions we encounter.

The new IP Policy allows for researchers to independently generate and complete certain outbound academic MTAs if specific criteria are met. In addition, we have implemented a new form for initiating inbound MTAs. Please click the link above for instructions and to download the forms.

@ChildrensTIDO on Twitter

Connect with us

youtube

Terms and Conditions children's hospital
Site Designed and Developed by Genuine